Document is current
Any future updates will be listed below
-
Authors
Farhani, Ibrahim
Yamchi, Ahad
Nikoo, Hadi Razavi
Shamsabadi, Fatemeh T.
Abdoli, Shahriyar
Cheng, R. Holland
Shahbazi, Majid
-
Funding
Funding for this research was provided by:
Golestan University of Medical Sciences and AryaTinaGene Biopharmaceutical Company
- License Information
-
More Information
Article History
Received: 16 July 2025
Accepted: 21 January 2026
First Online: 2 February 2026
Declarations
:
: The authors declare no competing interests.
: All animal experiments were carried out according to the standard approved animal care guidelines and protocols, which were approved by the animal ethics committee of Golestan University of Medical Sciences, Gorgan, Iran, (IR.GOUMS.REC.1401.016).
: This study was approved by the Faculty of New Medical Technology in Gorgan (Iran), in accordance with the ethical principles of animal experimentation, and was also conducted with the approval of the Research Deputy and the Ethics Committee of Golestan University of Medical Sciences (Approval ID: 1401.016). The project is in accordance with the ARRIVE guidelines (PLoS Bio 8(6), e1000412, 2010).
